{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:51:26Z","timestamp":1765961486275,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"scientific research projects coordination unit of istanbul university-cerrahpasa","award":["ID: 34942","Project code: TSA-2020-34942."],"award-info":[{"award-number":["ID: 34942","Project code: TSA-2020-34942."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10067-022-06067-5","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T08:03:22Z","timestamp":1642579402000},"page":"1523-1533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Asymptomatic SARS-CoV-2 seropositivity: patients with childhood-onset rheumatic diseases versus healthy children"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6963-9668","authenticated-orcid":false,"given":"Fatih","family":"Haslak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0596-1551","authenticated-orcid":false,"given":"Dogukan","family":"Ozbey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7834-4909","authenticated-orcid":false,"given":"Mehmet","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2400-6955","authenticated-orcid":false,"given":"Amra","family":"Adrovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5365-3457","authenticated-orcid":false,"given":"Sezgin","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0101-9585","authenticated-orcid":false,"given":"Oya","family":"Koker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8046-3907","authenticated-orcid":false,"given":"Ayten","family":"Aliyeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1663-015X","authenticated-orcid":false,"given":"Vafa","family":"Guliyeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3209-7121","authenticated-orcid":false,"given":"Gamze","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9828-5603","authenticated-orcid":false,"given":"Gulmelek","family":"Inanli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1072-3846","authenticated-orcid":false,"given":"Bekir S.","family":"Kocazeybek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1125-7720","authenticated-orcid":false,"given":"Ozgur","family":"Kasapcopur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8459-2872","authenticated-orcid":false,"given":"Kenan","family":"Barut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"6067_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/dmp.2021.90","volume":"25","author":"ML Ram\u00edrez","year":"2021","unstructured":"Ram\u00edrez ML, Martinez SM, Bessone CDV, Allemandi DA, Quinteros DA (2021) COVID-19: epidemiological situation of Argentina and its neighbor countries after three months of pandemic. Disaster Med Public Health Prep 25:1\u20137","journal-title":"Disaster Med Public Health Prep"},{"issue":"6","key":"6067_CR2","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/apa.15270","volume":"109","author":"JF Ludvigsson","year":"2020","unstructured":"Ludvigsson JF (2020) Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 109(6):1088\u20131095","journal-title":"Acta Paediatr"},{"issue":"9","key":"6067_CR3","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s00296-020-04645-x","volume":"40","author":"F Haslak","year":"2020","unstructured":"Haslak F, Yildiz M, Adrovic A, Sahin S, Koker O, Aliyeva A et al (2020) Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic. Rheumatol Int 40(9):1423\u20131431","journal-title":"Rheumatol Int"},{"issue":"6","key":"6067_CR4","first-page":"1271","volume":"38","author":"M Yildiz","year":"2020","unstructured":"Yildiz M, Haslak F, Adrovic A, Sahin S, Barut K, Kasapcopur O (2020) The frequency and clinical course of COVID-19 infection in children with juvenile idiopathic arthritis. Clin Exp Rheumatol 38(6):1271\u20131272","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"6067_CR5","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/annrheumdis-2020-217424","volume":"79","author":"S Monti","year":"2020","unstructured":"Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C (2020) Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis 79(5):667\u2013668","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"6067_CR6","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s10067-020-05189-y","volume":"39","author":"DD Ou\u00e9draogo","year":"2020","unstructured":"Ou\u00e9draogo DD, Tiendr\u00e9b\u00e9ogo WJS, Kabor\u00e9 F, Ntsiba H (2020) COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments. Clin Rheumatol 39(7):2069\u20132075","journal-title":"Clin Rheumatol"},{"key":"6067_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijid.2020.08.076","volume":"100","author":"LA Nikolai","year":"2020","unstructured":"Nikolai LA, Meyer CG, Kremsner PG, Velavan TP (2020) Asymptomatic SARS coronavirus 2 infection: invisible yet invincible. Int J Infect Dis 100:112\u2013116","journal-title":"Int J Infect Dis"},{"issue":"6","key":"6067_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s12250-020-00312-4","volume":"35","author":"J Cai","year":"2020","unstructured":"Cai J, Wang X, Zhao J, Ge Y, Xu J, Tian H et al (2020) Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection in children. Virol Sin 35(6):803\u2013810","journal-title":"Virol Sin"},{"key":"6067_CR9","doi-asserted-by":"crossref","unstructured":"Barcellini L, Forlanini F, Sangiorgio A, Gambacorta G, Alberti L, Meta A, et al. (2021) Does school reopening affect SARS-CoV-2 seroprevalence among school-age children in Milan? PLoS One 16(9):e0257046.","DOI":"10.1371\/journal.pone.0257046"},{"issue":"8","key":"6067_CR10","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677\u20132686","journal-title":"Arthritis Rheum"},{"issue":"4","key":"6067_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/rheumatology\/ken509","volume":"48","author":"F Yal\u00e7inkaya","year":"2009","unstructured":"Yal\u00e7inkaya F, Ozen S, Oz\u00e7akar ZB, Aktay N, Cakar N, D\u00fczova A et al (2009) A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford) 48(4):395\u2013398","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"6067_CR12","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31(2):390\u2013392","journal-title":"J Rheumatol"},{"issue":"9","key":"6067_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.7326\/M20-0504","volume":"172","author":"SA Lauer","year":"2020","unstructured":"Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR et al (2020) The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med 172(9):577\u2013582","journal-title":"Ann Intern Med"},{"key":"6067_CR14","first-page":"372","volume":"98","author":"DW Al-Sadeq","year":"2020","unstructured":"Al-Sadeq DW, Nasrallah GK (2020) The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review. J Infect Dis 98:372\u2013380","journal-title":"J Infect Dis"},{"issue":"5","key":"6067_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/jpids\/piaa102","volume":"9","author":"AB Patel","year":"2020","unstructured":"Patel AB, Clifford A, Creaden J, Kato K, Malakooti MR, Muller WJ et al (2020) Severe acute respiratory syndrome coronavirus 2 point prevalence among asymptomatic hospitalized children and subsequent healthcare worker evaluation. J Pediatric Infect Dis Soc 9(5):617\u2013619","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"3","key":"6067_CR16","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1002\/jmv.26689","volume":"93","author":"S Desmet","year":"2020","unstructured":"Desmet S, Ekinci E, Wouters I, Decru B, Beuselinck K, Malhotra-Kumar S et al (2020) No SARS-CoV-2 carriage observed in children attending daycare centers during the intial weeks of the epidemic in Belgium. J Med Virol 93(3):1828\u20131831","journal-title":"J Med Virol"},{"issue":"4","key":"6067_CR17","first-page":"184","volume":"37","author":"F Ha\u015flak","year":"2020","unstructured":"Ha\u015flak F, Y\u0131ld\u0131z M, Adrovic A, Barut K, Kasap\u00e7opur \u00d6 (2020) Childhood rheumatic diseases and COVID-19 pandemic: an intriguing linkage and a new horizon. Balkan Med J 37(4):184\u2013188","journal-title":"Balkan Med J"},{"issue":"24","key":"6067_CR18","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1056\/NEJMoa2006100","volume":"382","author":"DF Gudbjartsson","year":"2020","unstructured":"Gudbjartsson DF, Helgason A, Jonsson H, Magnusson OT, Melsted P, Norddahl GL et al (2020) Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med 382(24):2302\u20132315","journal-title":"N Engl J Med"},{"issue":"4","key":"6067_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ped4.12231","volume":"4","author":"R Wang","year":"2020","unstructured":"Wang R, Jin F, Cao S, Yuan H, Qu J, Zhang J et al (2020) Seroprevalence of SARS-CoV-2 infections among children visiting a hospital. Pediatr Investig 4(4):236\u2013241","journal-title":"Pediatr Investig"},{"issue":"7798","key":"6067_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273","journal-title":"Nature"},{"key":"6067_CR21","doi-asserted-by":"crossref","unstructured":"Chen J, Jiang Q, Xia X, Liu K, Yu Z, Tao W, et al. (2020) Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging cell 19(7).","DOI":"10.1111\/acel.13168"},{"issue":"9","key":"6067_CR22","first-page":"2116","volume":"28","author":"C Huemer","year":"2001","unstructured":"Huemer C, Huemer M, Dorner T, Falger J, Schacherl H, Bernecker M et al (2001) Incidence of pediatric rheumatic diseases in a regional population in Austria. J Rheumatol 28(9):2116\u20132119","journal-title":"J Rheumatol"},{"issue":"4","key":"6067_CR23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.semarthrit.2020.05.001","volume":"50","author":"X Michelena","year":"2020","unstructured":"Michelena X, Borrell H, L\u00f3pez-Corbeto M, L\u00f3pez-Lasanta M, Moreno E, Pascual-Pastor M et al (2020) Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs. Semin Arthritis Rheum 50(4):564\u2013570","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"6067_CR24","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1016\/S2665-9913(20)30286-1","volume":"2","author":"F Hooijberg","year":"2020","unstructured":"Hooijberg F, Boekel L, Vogelzang EH, Leeuw M, Boers M, van Vollenhoven R et al (2020) Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population. Lancet Rheumatol 2(10):e583\u2013e585","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"6067_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.celrep.2019.12.014","volume":"30","author":"E Katsuyama","year":"2020","unstructured":"Katsuyama E, Suarez-Fueyo A, Bradley SJ, Mizui M, Marin AV, Mulki L et al (2020) The CD38\/NAD\/SIRTUIN1\/EZH2 axis mitigates cytotoxic CD8 T cell function and identifies patients with SLE prone to infections. Cell Rep 30(1):112\u201323.e4","journal-title":"Cell Rep"},{"key":"6067_CR26","doi-asserted-by":"crossref","unstructured":"Sawalha AH, Zhao M, Coit P, Lu Q (2020) Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clin Immunol 215:108410.","DOI":"10.1016\/j.clim.2020.108410"},{"issue":"13","key":"6067_CR27","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1177\/0961203320961848","volume":"29","author":"A Mason","year":"2020","unstructured":"Mason A, Rose E, Edwards CJ (2020) Clinical management of Lupus patients during the COVID-19 pandemic. Lupus 29(13):1661\u20131672","journal-title":"Lupus"},{"key":"6067_CR28","doi-asserted-by":"crossref","unstructured":"Favalli EG, Gerosa M, Murgo A, Caporali R (2021) Are patients with systemic lupus erythematosus at increased risk for COVID-19? Ann Rheum Dis 80(2):e25.","DOI":"10.1136\/annrheumdis-2020-217787"},{"issue":"5","key":"6067_CR29","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00296-020-04566-9","volume":"40","author":"V Venerito","year":"2020","unstructured":"Venerito V, Lopalco G, Iannone F (2020) COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence. Rheumatol Int 40(5):827\u2013828","journal-title":"Rheumatol Int"},{"key":"6067_CR30","doi-asserted-by":"crossref","unstructured":"Gautret P, Lagier J-C, Parola P, Meddeb L, Mailhe M, Doudier B, et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 57(1):106243","DOI":"10.1016\/j.ijantimicag.2020.106243"},{"issue":"12","key":"6067_CR31","doi-asserted-by":"publisher","first-page":"819","DOI":"10.7326\/M20-1223","volume":"172","author":"AH Kim","year":"2020","unstructured":"Kim AH, Sparks JA, Liew JW, Putman MS, Berenbaum F, Duarte-Garc\u00eda A et al (2020) A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19. Ann Intern Med 172(12):819\u2013821","journal-title":"Ann Intern Med"},{"issue":"6","key":"6067_CR32","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/annrheumdis-2020-217566","volume":"79","author":"A Mathian","year":"2020","unstructured":"Mathian A, Mahevas M, Rohmer J, Roumier M, Cohen-Aubart F, Amador-Borrero B et al (2020) Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Ann Rheum Dis 79(6):837\u2013839","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"6067_CR33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/jmv.26286","volume":"93","author":"A Ferreira","year":"2021","unstructured":"Ferreira A, Oliveira ESA, Bettencourt P (2021) Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection. J Med Virol 93(2):755\u2013759","journal-title":"J Med Virol"},{"issue":"4","key":"6067_CR34","first-page":"166","volume":"156","author":"F Tejada Cifuentes","year":"2021","unstructured":"Tejada Cifuentes F, Lloret Callejo \u00c1, Tirado Pel\u00e1ez MJ, Rubio Pulido O, Ruiz-Morote Arag\u00f3n M, Fern\u00e1ndez Urrusuno R et al (2021) Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine. Med Clin (Engl Ed) 156(4):166\u2013171","journal-title":"Med Clin (Engl Ed)"},{"issue":"1","key":"6067_CR35","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S2665-9913(20)30378-7","volume":"3","author":"CT Rentsch","year":"2021","unstructured":"Rentsch CT, DeVito NJ, MacKenna B, Morton CE, Bhaskaran K, Brown JP et al (2021) Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform. Lancet Rheumatol 3(1):e19\u2013e27","journal-title":"Lancet Rheumatol"},{"key":"6067_CR36","doi-asserted-by":"crossref","unstructured":"Carbillon L, Benbara A, Boujenah J (2020) Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Ann Rheum Dis 80: e54.","DOI":"10.1136\/annrheumdis-2020-217847"},{"key":"6067_CR37","doi-asserted-by":"crossref","unstructured":"Bourguiba R, Delplanque M, Vinit C, Ackermann F, Savey L, Grateau G, et al. (2020) Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area. Ann Rheum Dis; annrheumdis-2020\u2013218707","DOI":"10.1136\/annrheumdis-2020-218707"},{"issue":"4","key":"6067_CR38","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00296-021-04812-8","volume":"41","author":"SC G\u00fcven","year":"2021","unstructured":"G\u00fcven SC, Erden A, Karaka\u015f \u00d6, Arma\u011fan B, Usul E, Omma A et al (2021) COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study. Rheumatol Int 41(4):715\u2013719","journal-title":"Rheumatol Int"},{"issue":"1","key":"6067_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/1568010053622948","volume":"4","author":"D Cattan","year":"2005","unstructured":"Cattan D (2005) MEFV mutation carriers and diseases other than familial Mediterranean fever: proved and non-proved associations; putative biological advantage. Curr Drug Targets Inflamm Allergy 4(1):105\u2013112","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"3","key":"6067_CR40","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.chom.2016.07.018","volume":"20","author":"LK Chung","year":"2016","unstructured":"Chung LK, Park YH, Zheng Y, Brodsky IE, Hearing P, Kastner DL et al (2016) The Yersinia virulence factor YopM hijacks host kinases to inhibit type III effector-triggered activation of the pyrin inflammasome. Cell Host Microbe 20(3):296\u2013306","journal-title":"Cell Host Microbe"},{"key":"6067_CR41","doi-asserted-by":"crossref","unstructured":"Della-Torre E, Della-Torre F, Kusanovic M, Scotti R, Ramirez GA, Dagna L, et al. (2020) Treating COVID-19 with colchicine in community healthcare setting. Clin Immunol 217:108490.","DOI":"10.1016\/j.clim.2020.108490"},{"issue":"8","key":"6067_CR42","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1136\/annrheumdis-2021-219845","volume":"80","author":"H Bower","year":"2021","unstructured":"Bower H, Frisell T, Di Giuseppe D, Delcoigne B, Ahlenius GM, Baecklund E et al (2021) Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study. Ann Rheum Dis 80(8):1086\u20131093","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6067_CR43","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.semarthrit.2020.09.012","volume":"50","author":"A Marino","year":"2020","unstructured":"Marino A, Romano M, Gattinara M, Cimaz R (2020) Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members. Semin Arthritis Rheum 50(6):1214\u20131215","journal-title":"Semin Arthritis Rheum"},{"key":"6067_CR44","doi-asserted-by":"crossref","unstructured":"Marques CDL, Kakehasi AM, Pinheiro MM, Mota LMH, Albuquerque CP, Silva CR, et al. (2021) High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry. RMD Open 7(1): e001461","DOI":"10.1136\/rmdopen-2020-001461corr1"},{"issue":"7","key":"6067_CR45","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3899\/jrheum.200755","volume":"48","author":"J Bachiller-Corral","year":"2021","unstructured":"Bachiller-Corral J, Boteanu A, Garcia-Villanueva MJ, de la Puente C, Revenga M, Diaz-Miguel MC et al (2021) Risk of severe coronavirus infection (COVID-19) in patients with inflammatory rheumatic diseases. J Rheumatol 48(7):1098\u20131102","journal-title":"J Rheumatol"},{"key":"6067_CR46","doi-asserted-by":"crossref","unstructured":"Kowitdamrong E, Puthanakit T, Jantarabenjakul W, Prompetchara E, Suchartlikitwong P, Putcharoen O, et al. (2020) Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019. PloS one 15(10):e0240502.","DOI":"10.1371\/journal.pone.0240502"},{"issue":"2","key":"6067_CR47","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/jmv.26355","volume":"93","author":"C Zhang","year":"2021","unstructured":"Zhang C, Lin L, Tang D, Liu F, Li M, Li Q et al (2021) Antibody responses to SARS-CoV-2 in healthy individuals returning to Shenzhen. J Med Virol 93(2):1154\u20131157","journal-title":"J Med Virol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06067-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06067-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06067-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T11:05:11Z","timestamp":1651316711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06067-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["6067"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06067-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2022,1,19]]},"assertion":[{"value":"17 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of our University (04\/16\/20\u201329430533\u2013604.01\u201301-54959).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"A written informed consent was obtained from all the participants included in this study and no identifying information of any participant was included in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Patients or the public were not involved in the design, or conduct, or reporting, or dissemination plans of our research.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"The patient and public involvement statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}